Application Notes & Case Studies

  1. Overcoming Unexpected Obstacles In A Phase 1 Study 1/29/2025

    Discover how the implementation of mobile vision clinics (MVCs) was used to enhance efficiency in a Phase 1 clinical trial.

  2. Advancing Rare Disease Clinical Trials With Point-Of-Need Eye Assessments 1/29/2025

    During the COVID-19 pandemic, Applied Genetic Technologies Corporation (AGTC) faced significant hurdles in enrolling participants due to travel restrictions and site limitations.

  3. Use Case: A Patient-Centric Approach To Site Selection 1/27/2025

    Discover how Citeline’s robust datasets, combined with real-world data, inform intelligent site and investigator selection for a rare, autoimmune disease. 

  4. Optimizing Chronic Cough Phase 3 Trials With Point-Of-Need Eye Assessments 1/15/2025

    Collaboration was key for Company W to overcome challenges with an FDA-mandated ocular substudy, including limited resources for ocular assessments and logistical difficulties

  5. Optimizing Early-Stage Oncology 1/14/2025

    A strategic partnership enables a U.S. biotech company to address the struggles with their Phase I first-in-human oncology trial.

  6. Addressing Site Selection Challenges In DMD Gene Therapy Studies 1/14/2025

    Effective site selection is critical for the success of DMD gene therapy trials. This study details innovative methodologies employed to streamline and improve site identification.

  7. Breaking Free From Process Paralysis In Clinical Trials 1/13/2025

    Explore the implementation of CRIO’s eSource solution by a leading pharmaceutical company to overcome process paralysis in clinical research.

  8. Elevating Diverse Patient Voices To Inspire Clinical Trial Participation 1/9/2025

    Explore the innovative approach taken during this clinical trial partnership to address the underrepresentation of minority communities in clinical trials through digital storytelling.

  9. How Syneos Health Tackles Protocol Complexities 1/7/2025

    Explore solutions employed by Syneos Health, a global contract research organization, to optimize Phase IIV clinical trials, particularly under a complex adaptive trial protocol.

  10. Taking Research In-House With CRIO: SciTech's Multi-Center Phase 1 Study 1/6/2025

    Explore the success story of an early-stage clinical pharmaceutical company that effectively navigated funding constraints when conducting its Phase 1 study without a third-party CRO.